Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Other Working Capital Changes (2016 - 2025)

Rein Therapeutics filings provide 10 years of Other Working Capital Changes readings, the most recent being -$1.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes changed N/A year-over-year to -$1.0 million, compared with a TTM value of -$1.1 million through Dec 2025, down 3268.75%, and an annual FY2025 reading of $32128.0, down 62.31% over the prior year.
  • Other Working Capital Changes hit -$1.0 million in Q4 2025 for Rein Therapeutics, down from $32128.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $264000.0 in Q2 2022, with the low at -$1.0 million in Q4 2025.
  • Median Other Working Capital Changes over the past 5 years was $5021.5 (2021), compared with a mean of -$138488.7.
  • The largest YoY upside for Other Working Capital Changes was 13100.0% in 2022 against a maximum downside of 3053.33% in 2022.
  • Year by year, Other Working Capital Changes stood at -$30000.0 in 2021, then crashed by 3053.33% to -$946000.0 in 2022, then skyrocketed by 95.67% to -$41000.0 in 2023, then soared by 307.91% to $85243.0 in 2024, then crashed by 1327.08% to -$1.0 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$1.0 million, $32128.0, and $23596.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.